Sudarshan Pharma Industries soars on entering into Rent Agreement with Daundi Biological
Sudarshan Pharma Industries is currently trading at Rs. 51.50, up by 0.52 points or 1.02% from its previous closing of Rs. 50.98 on the BSE.
The scrip opened at Rs. 53.49 and has touched a high and low of Rs. 53.50 and Rs. 51.00 respectively. So far 328000 shares were traded on the counter.
The BSE group 'MT' stock of face value Rs. 1 has touched a 52 week high of Rs. 53.50 on 07-Jan-2025 and a 52 week low of Rs. 5.82 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 53.50 and Rs. 44.10 respectively. The current market cap of the company is Rs. 1227.36 crore.
The promoters holding in the company stood at 57.39%, while Institutions and Non-Institutions held 13.07% and 29.54% respectively.
Sudarshan Pharma Industries has entered into a Rent Agreement with Daundi Biological to acquire premises for a period of 5 years commencing from December 29, 2024 to set up a new Research & Development formulation centre in the city of Dehradun, Uttarakhand, India. It is expected to commence the operations of the formulation R&D Centre in the month of March 2025.
Sudarshan Pharma Industries is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.
